Specific Antigen Working Group / Fleming / Nacusi LP / Prostate Cancer Clinical Trials Working Group / Pearson / Ford / Cox / Phase III Southwest Oncology Group / Hess / /
Country
Austria / United States / /
Currency
pence / / /
Event
FDA Phase / Man-Made Disaster / /
IndustryTerm
prostate cancer therapies / microfluidic device / treatment of prostate cancer / treatment of hormone‑refractory prostate cancer / treatment of advanced prostate cancer / Treatment of Cancer / metabolic products / prostate cancer treatment / /
MarketIndex
Functional Living / /
MedicalCondition
metastatic prostate cancer / bulky visceral disease / castrate‑resistant prostate cancer / stomatitis / prostatic cancer / metastatic castrate‑resistant prostate cancer / Functional Living Index‑Cancer / INTRODUCTION Prostate cancer / diarrhea / prostate cancer / breast cancer / metastatic castrate‑resistant prostate cancer progressing / leukemia / tumor / symptomatic hormone‑resistant prostate cancer / General resistance mechanisms Limited tumor / Cancer / hormone‑refractory prostate cancer / tumors / castration‑resistant prostate cancer / e.g. neutropenia / advanced solid tumors / neutropenia / metastatic carcinoma / progressive prostate cancer / refractory prostate cancer / stable disease / rapidly expanding disease / taxane‑resistant metastatic breast cancer / solid tumors / thrombocytopenia / peripheral neuropathy / only modest anti‑prostate cancer / LNCaP prostate tumor / febrile neutropenia / resistant prostate cancer / MS / androgen‑independent prostate cancer / refractory prostate carcinoma / advanced androgen‑independent prostate cancer / advanced prostate cancer / soft tissue disease / AR using circulating tumor / disease / prostate‑cancer / advanced castration‑resistant prostate cancer / androgen‑independent prostate carcinoma / metastatic hormone‑refractory prostate cancer / pain / Castration‑recurrent prostate cancer / Jemal A. Cancer / human prostate cancer / transient disease / objective tumor / symptomatic / metastatic carcinoma / human prostate carcinoma / advanced refractory prostate cancer / prostate carcinoma / anemia / metastatic castration‑resistant prostate cancer / hormone‑refractory prostate carcinoma / castration‑resistant tumor / /
Asian Journal of Andrology[removed], 334–340 © 2014 AJA, SIMM & SJTU. All rights reserved 1008-682X www.asiaandro.com; www.ajandrology.com